Fetal Growth Retardation Clinical Trial
Official title:
Prediction of Late Fetal Growth Restriction in Uncomplicated Pregnancies Using Cerebroplacental Ratio: a Prospective Cohort Study
To investigate the screening performance of CPR and biophysical profile score for the prediction of composite of adverse neonatal morbidity and mortality and operative delivery (CS or instrumental) for intrapartum fetal distress in low-risk pregnancies
Fetal growth is a dynamic process and its assessment requires multiple observations over time. In most women, placental function is sufficient to allow appropriate fetal growth throughout pregnancy, however in some, it may be not near term or during labor leading to intrapartum compromise Small for gestational age (SGA) is estimated fetal weight (EFW) or abdominal circumference (AC) below the 10th percentile of given reference ranges Fetal growth restriction (FGR) is fetus that has not achieved its growth potential. There are early-onset (< 32 weeks) and late-onset (≥ 32 weeks) types. Late FGR is defined as - AC/EFW < 3rd centile Or at least two out of three of: 1. AC/EFW < 10th centile 2. AC/EFW crossing centiles >2 quartiles 3. Cerebroplacental ratio (CPR) <5th centile or Umbilical artery Pusitility Index(UAPI )>95th centile FGR fetuses will not necessarily be SGA at delivery and vice versa. In fact, most SGA are likely to be 'constitutionally' small CPR is the ratio of the Middle cerebral artery Pulsatility Index (MCAPI) to (UAPI). The CPR gradually rises until around the 34th week and subsequently slowly declines until term. Its use has been echoed recently because of association of an abnormal ratio with fetal distress in labor requiring emergency cesarean section , a lower cord pH, admission to the intensive care unit and poor neurological outcomes The biophysical profile (BPP) abnormalities that characterize late FGR include alteration of fetal breathing, oligohydramnios and loss of fetal heart rate reactivity on conventional cardiotocography ( CTG). It seems that BPP becomes abnormal only shortly before stillbirth . ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05899101 -
The Impact of Opioid and Cannabis Exposure on Fetal Growth
|
||
Completed |
NCT04502823 -
Management of Fetal Growth Restriction at Term: Angiogenic Factors Versus Feto-placental Doppler
|
N/A | |
Not yet recruiting |
NCT03625518 -
Mode of Induction in Fetal Growth Restriction and Its Affects on Fetal and Maternal Outcomes
|
Early Phase 1 | |
Completed |
NCT05176041 -
SLE Therapy Changes in Pregnancy and Relation to Pregnancy Outcome
|
||
Completed |
NCT02379728 -
Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth
|
N/A | |
Completed |
NCT01695070 -
Melatonin to Prevent Brain Injury in Unborn Growth Restricted Babies
|
Phase 4 | |
Completed |
NCT01352234 -
Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia
|
Phase 4 | |
Completed |
NCT04289350 -
Day to Day Variation in Fetal Heart Rate Variability
|
||
Recruiting |
NCT03662178 -
Investigating the Structured Use of Ultrasound Scanning for Fetal Growth
|
||
Recruiting |
NCT05023161 -
Non-invasive Placental Chromosome Exploration of Intrauterine Growth Restriction
|
||
Completed |
NCT02590536 -
A Trial Evaluating the Role of Sildenafil in the Treatment of Fetal Growth Restriction
|
Phase 3 | |
Not yet recruiting |
NCT05029778 -
Arginine + Citrulline as a Supplement for Weight Gain in Fetus With a Decrease in Their Growth Curve
|
Phase 4 | |
Recruiting |
NCT05576207 -
BEP Supplementation Research in Bangladesh (JiVitA-BEP-IR)
|
N/A | |
Active, not recruiting |
NCT05160649 -
Effect of Covid 19 Infection on Fetomaternal Outcome
|
||
Completed |
NCT02280031 -
Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial.
|
Phase 2 | |
Recruiting |
NCT04389099 -
MRI Angiography of Physiological and Pathological Pregnancy Placentas Ex-vivo
|
||
Recruiting |
NCT06039319 -
Acute Effects of Maternal Exercise and the Growth Restricted Pregnancy
|
||
Recruiting |
NCT05651347 -
Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction
|
Phase 3 | |
Recruiting |
NCT02336243 -
A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders
|
Phase 3 | |
Active, not recruiting |
NCT01594463 -
Routine Ultrasound Screening in the Third Trimester
|
N/A |